Screener
AngioDynamics ANGO EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from AngioDynamics’s reported figures.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026. Open the filing →
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
FAQ
- What is AngioDynamics's EBIT?
- AngioDynamics (ANGO) reported EBIT of -$10.2M in Q1 2026.
- How has AngioDynamics's EBIT changed year-over-year?
- AngioDynamics's EBIT decreased by 76.1% year-over-year, from -$5.79M to -$10.2M.
- What is the long-term trend for AngioDynamics's EBIT?
- Over 4 years (2022 to 2026), AngioDynamics's EBIT has grown at a 8.8% compound annual growth rate (CAGR), from -$28.47M to -$39.93M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about AngioDynamics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude